These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30737795)

  • 41. An audit of cytoreductive surgeries in ovarian cancer from a rural based cancer center.
    Dessai SB; Patil VM; Chakraborty S; Babu S; Bhattacharjee A; Nayanar S; Vikram S; Balasubramanian S
    Indian J Cancer; 2016; 53(2):284-287. PubMed ID: 28071628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary debulking surgery versus neo-adjuvant chemotherapy in stage III/IV ovarian cancer: Comparison of perioperative morbidity and survival data in Pakistani women.
    Chishti U; Aziz AB
    J Pak Med Assoc; 2015 Mar; 65(3):306-9. PubMed ID: 25933567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
    Fotopoulou C; Jones BP; Savvatis K; Campbell J; Kyrgiou M; Farthing A; Brett S; Roux R; Hall M; Rustin G; Gabra H; Jiao L; Stümpfle R
    Arch Gynecol Obstet; 2016 Sep; 294(3):607-14. PubMed ID: 27040418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Neoadjuvant Chemotherapy on the Rate of Bowel Resection in Advanced Epithelial Ovarian Cancer.
    Philip CA; Pelissier A; Bonneau C; Hequet D; Rouzier R; Pouget N
    Anticancer Res; 2016 Sep; 36(9):4865-71. PubMed ID: 27630342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.
    Salani R; Zahurak ML; Santillan A; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2007 Dec; 107(3):495-9. PubMed ID: 17854870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Well-trained gynecologic oncologists can perform bowel resection and upper abdominal surgery safely.
    Nishikimi K; Tate S; Kato K; Matsuoka A; Shozu M
    J Gynecol Oncol; 2020 Jan; 31(1):e3. PubMed ID: 31788993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bowel surgery for epithelial ovarian cancer--an early case series.
    Chia YN; Tay EH; Cheong DM; Eu KW; Low J; Ho TH; Yam KL
    Ann Acad Med Singap; 2003 Sep; 32(5):661-4. PubMed ID: 14626798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.
    Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN
    J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Kranawetter M; Ataseven B; Grimm C; Schneider S; Riss S; Alesina P; Prader S; Walz MK; Harpain F; Stift A; Heitz F; Reinthaller A; Polterauer S; Harter P; du Bois A
    Gynecol Oncol; 2019 Sep; 154(3):577-582. PubMed ID: 31235241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indocyanine green-enhanced fluorescence to assess bowel perfusion during laparoscopic colorectal resection.
    Boni L; David G; Dionigi G; Rausei S; Cassinotti E; Fingerhut A
    Surg Endosc; 2016 Jul; 30(7):2736-42. PubMed ID: 26487209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Right Upper Abdominal Resections in Advanced Stage Ovarian Cancer.
    Bacalbasa N; Balescu I; Diaconu C; Iliescu L; Filipescu A; Pop C; Dima S; Vilcu M; Brezean I
    In Vivo; 2020; 34(3):1487-1492. PubMed ID: 32354951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
    Gueli Alletti S; Bottoni C; Fanfani F; Gallotta V; Chiantera V; Costantini B; Cosentino F; Ercoli A; Scambia G; Fagotti A
    Am J Obstet Gynecol; 2016 Apr; 214(4):503.e1-503.e6. PubMed ID: 26529370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
    Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
    Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
    Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical implications of mesenteric lymph node metastasis from advanced ovarian cancer after bowel resection.
    Baiocchi G; Cestari LA; Macedo MP; Oliveira RA; Fukazawa EM; Faloppa CC; Kumagai LY; Badiglian-Filho L; Menezes AN; Cunha IW; Soares FA
    J Surg Oncol; 2011 Sep; 104(3):250-4. PubMed ID: 21472733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer.
    Song YJ; Lim MC; Kang S; Seo SS; Park JW; Choi HS; Park SY
    Gynecol Oncol; 2009 Aug; 114(2):183-7. PubMed ID: 19427682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery.
    Uccella S; Bosco M; Mezzetto L; Garzon S; Maggi V; Giacopuzzi S; Antonelli A; Pinali L; Zorzato PC; Festi A; Polati E; Montemezzi S; De Manzoni G; Franchi MP; Veraldi GF
    Gynecol Oncol; 2023 Dec; 179():42-51. PubMed ID: 37922861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.